Boswellia (Frankincense) for Joint Pain Relief

Research suggests that Boswellia serrata, often studied alongside complementary compounds like curcumin and turmeric, shows meaningful promise for reducing joint pain and inflammation associated with osteoarthritis and spinal conditions, with several randomized controlled trials and observational studies reporting improvements in pain scores, stiffness, and physical function compared to placebo. The supporting evidence includes a 2025 placebo-controlled trial in spondylitis patients, a 90-day observational study in knee osteoarthritis, and a 2018 RCT using a Boswellia-containing herbal blend, all of which reported statistically significant benefits, while review-level evidence points to plausible biological mechanisms involving suppression of inflammatory pathways such as COX-2, 5-LOX, and NFĸB. However, the body of evidence carries notable limitations: most positive findings come from small or short-duration studies, Boswellia is rarely tested in isolation making it difficult to attribute effects to the herb alone, and a well-designed 2021 RCT found no significant benefit for hand osteoarthritis from a Boswellia-containing supplement combination, underscoring that results are not universally consistent. Reviews in the field broadly conclude that while the therapeutic potential is promising, larger and more rigorous independent trials are needed before firm clinical conclusions can be drawn.